Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.82 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.82 |
| ▸ | MAPT | P10636 | 8/20 | 0.82 |
| ▸ | HTT | P42858 | 5/20 | 0.82 |
| ▸ | DDX3X | O00571 | 2/20 | 0.82 |
| ▸ | POLB | P06746 | 2/20 | 0.82 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.82 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.72 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.72 |
| ▸ | NPC1 | O15118 | 2/20 | 0.69 |
| ▸ | LMNA | P02545 | 1/20 | 0.69 |
| ▸ | GAA | P10253 | 3/20 | 0.66 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.63 |
| ▸ | CA12 | O43570 | 2/20 | 0.63 |
| ▸ | CA1 | P00915 | 2/20 | 0.63 |
| ▸ | CA2 | P00918 | 2/20 | 0.63 |
| ▸ | CA9 | Q16790 | 2/20 | 0.63 |
| ▸ | BAZ1A | Q9NRL2 | 2/20 | 0.63 |
| ▸ | CA5A | P35218 | 1/20 | 0.63 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1047211 | 0.91 | MEN1 (1.00) | MEN1KMT2AMAPTHTTDDX3X | |
| SCHEMBL27880343 | 0.90 | MEN1 (0.70) | MEN1KMT2AMAPTHTTDDX3X | |
| SCHEMBL29494985 | 0.90 | MEN1 (0.79) | MEN1KMT2AMAPTHTTDDX3X | |
| SCHEMBL22092547 | 0.90 | MEN1 (0.79) | MEN1KMT2AMAPTHTTDDX3X | |
| SCHEMBL17084065 | 0.89 | MEN1 (0.96) | MEN1KMT2AMAPTHTTDDX3X | |
| SCHEMBL6129390 | 0.86 | MEN1 (0.90) | MEN1KMT2AMAPTHTTDDX3X | |
| SCHEMBL18013179 | 0.85 | TRPV1 (0.76) | MEN1KMT2AMAPTHTTDDX3X | |
| SCHEMBL546131 | 0.84 | TRPV1 (1.00) | MEN1KMT2AMAPTHTTDDX3X | |
| SCHEMBL27861138 | 0.84 | MEN1 (0.82) | MEN1KMT2AMAPTHTTDDX3X | |
| SCHEMBL2567642 | 0.84 | MEN1 (0.77) | MEN1KMT2AMAPTPOLBNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9932300-B2 | N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2018-04-03 | — | — | US | disclosed |
| US-20160318857-A1 | N,N'-Diarylurea Compounds and N,N'-Diarylthiourea Compounds as Inhibitors of Translation Initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2016-11-03 | — | — | US | disclosed |
| US-9421211-B2 | N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2016-08-23 | — | — | US | disclosed |
| US-20120115915-A1 | N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160318857-A1 | N,N'-Diarylurea Compounds and N,N'-Diarylthiourea Compounds as Inhibitors of Translation Initiation | NSUN2, EIF2AK2, RNGTT | MEN1 2936/4885KMT2A 761/4885MAPT 1631/4885 |
| US-20120115915-A1 | N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION | NSUN2, EIF2AK2, RNGTT | MEN1 2936/4885KMT2A 761/4885MAPT 1631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.